Luye Pharma Group is an international pharmaceutical company dedicated to developing, manufacturing, and selling innovative medications. With R&D centers in China, the U.S., and Europe, the company is an international leader in novel drug delivery systems such as microspheres, liposomes, and transdermal patches. It also has multiple innovative products under development in two categories: new chemical entities and antibodies. From 2021 to 2025, the company has had a total of 15 new drugs approved for marketing in one or multiple countries such as the U.S., several European countries, Japan, and China.

Luye Pharma has 8 manufacturing facilities worldwide, which follow internationally accepted, GMP-compliant quality management and control systems. To date, the company has launched over 30 products in the central nervous system, oncology, cardiovascular, and other therapeutic areas. It conducts business in over 80 countries and regions, including major pharmaceutical markets such as China, the U.S., Europe, and Japan, as well as fast-growing emerging markets.

Headquartered in Singapore, Luye Medical is the regional healthcare services arm of Luye Life Sciences Group. Through strategic acquisitions and partnerships with leading healthcare organizations, we adopt and develop world-leading technology as well as operational and management systems.
We are committed to provide quality integrated healthcare services to patients both locally and globally, and our vision is to become a leader in the global healthcare industry.

Through real-time fluorescent qPCR and next-generation sequencing (NGS) technologies in combination with data platforms, Luye Diagnostics provides clinical, intelligent, complete solutions in different stages of the disease.

Patronus Biotech is China’s first vaccine enterprise focused on the Universal Virus-like Particle (U-VLP®) technology platform. This technology overcomes the limitations of traditional VLP approaches regarding pathogen types, as well as technical bottlenecks in production capacity and stability. Multiple invention patents have been granted.